PubMed

Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemia.

Allen SL, Kolitz JE, Lundberg AS, Bennett JM, Capizzi RL, Budman DR.

Leuk Res. 2009 Sep 11. [Epub ahead of print]PMID: 19748672 [PubMed - as supplied by publisher]Related articles

Amonafide, a topoisomerase II inhibitor, is unaffected by P-glycoprotein-mediated efflux.

Chau M, Christensen JL, Ajami AM, Capizzi RL.

Leuk Res. 2008 Mar;32(3):465-73. Epub 2007 Sep 10.PMID: 17826829 [PubMed - indexed for MEDLINE]Related articles

Targeted radio-immunotherapy with Bexxar produces durable remissions in patients with late stage low grade non-Hodgkin's lymphomas.

Capizzi RL.

Trans Am Clin Climatol Assoc. 2004;115:255-72. Review.PMID: 17060972 [PubMed - indexed for MEDLINE]Related articlesFree article

Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab.

Bennett JM, Kaminski MS, Leonard JP, Vose JM, Zelenetz AD, Knox SJ, Horning S, Press OW, Radford JA, Kroll SM, Capizzi RL.

Blood. 2005 Jun 15;105(12):4576-82. Epub 2005 Feb 24.PMID: 15731177 [PubMed - indexed for MEDLINE]Related articlesFree article

Hepatocellular carcinoma after systemic chemotherapy: gadolinium-enhanced mr measurement of necrosis by volume histogram.

Jeong YY, Mitchell DG, Hann HW, Malin AK, Kang HK, Holland GA, Capizzi RL.

J Comput Assist Tomogr. 2001 Jul-Aug;25(4):624-8.PMID: 11473196 [PubMed - indexed for MEDLINE]Related articles

Chemoprotective and radioprotective effects of amifostine: an update of clinical trials.

Capizzi RL, Oster W.

Int J Hematol. 2000 Dec;72(4):425-35. Review.PMID: 11197208 [PubMed - indexed for MEDLINE]Related articles

1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats.

Napoli C, Salomone S, Godfraind T, Palinski W, Capuzzi DM, Palumbo G, D'Armiento FP, Donzelli R, de Nigris F, Capizzi RL, Mancini M, Gonnella JS, Bianchi A.

Stroke. 1999 Sep;30(9):1907-15.PMID: 10471444 [PubMed - indexed for MEDLINE]Related articlesFree article

Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: laboratory and clinical aspects.

Capizzi RL.

Semin Oncol. 1999 Apr;26(2 Suppl 7):72-81. Review.PMID: 10348264 [PubMed - indexed for MEDLINE]Related articles

The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine.

Capizzi RL.

Semin Oncol. 1999 Apr;26(2 Suppl 7):3-21. Review.PMID: 10348255 [PubMed - indexed for MEDLINE]Related articles

Recent developments and emerging options: the role of amifostine as a broad-spectrum cytoprotective agent.

Capizzi RL.

Semin Oncol. 1999 Apr;26(2 Suppl 7):1-2. No abstract available. PMID: 10348254 [PubMed - indexed for MEDLINE]Related articles

Clinical status and optimal use of amifostine.

Capizzi RL.

Oncology (Williston Park). 1999 Jan;13(1):47-59; discussion 63, 67. Review.PMID: 10027198 [PubMed - indexed for MEDLINE]Related articles

Amifostine stimulates formation of multipotent and erythroid bone marrow progenitors.

List AF, Heaton R, Glinsmann-Gibson B, Capizzi RL.

Leukemia. 1998 Oct;12(10):1596-602.PMID: 9766505 [PubMed - indexed for MEDLINE]Related articles

Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumour cells is maintained.

Taylor CW, Wang LM, List AF, Fernandes D, Paine-Murrieta GD, Johnson CS, Capizzi RL.

Eur J Cancer. 1997 Sep;33(10):1693-8.PMID: 9389935 [PubMed - indexed for MEDLINE]Related articles

Amifostine protects primitive hematopoietic progenitors against chemotherapy cytotoxicity.

List AF, Heaton R, Glinsmann-Gibson B, Capizzi RL.

Semin Oncol. 1996 Aug;23(4 Suppl 8):58-63.PMID: 8783669 [PubMed - indexed for MEDLINE]Related articles

Effects of amifostine and paclitaxel on growth of human ovarian carcinoma xenografts in the severe combined immune-deficient mouse: preliminary results.

Paine GD, Taylor CW, Lopez MH, Johnson CS, Capizzi RL.

Semin Oncol. 1996 Aug;23(4 Suppl 8):35-9.PMID: 8783664 [PubMed - indexed for MEDLINE]Related articles

Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancer.

Fleming RA, Capizzi RL, Muss HB, Smith S, Fernandes DJ, Homesley H, Loggie BW, Case L, Morris R, Russell GB, Richards F.

Clin Cancer Res. 1996 Jul;2(7):1107-14.PMID: 9816275 [PubMed - indexed for MEDLINE]Related articlesFree article

PALA enhancement of bromodeoxyuridine incorporation into DNA increases radiation cytotoxicity to human ovarian adenocarcinoma cells.

Yang JL, Fernandes DJ, Wheeler KT, Capizzi RL.

Int J Radiat Oncol Biol Phys. 1996 Mar 15;34(5):1073-9.PMID: 8600090 [PubMed - indexed for MEDLINE]Related articles

WR-1065, the active metabolite of amifostine (Ethyol), does not inhibit the cytotoxic effects of a broad range of standard anticancer drugs against human ovarian and breast cancer cells.

Alberts DS, Speicher LA, Krutzsch M, Wymer J, Capizzi RL, Conlon J, Barrett A, Aickin M.

Eur J Cancer. 1996;32A Suppl 4:S17-20.PMID: 8976817 [PubMed - indexed for MEDLINE]Related articles

The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine (Ethyol).

Capizzi RL.

Eur J Cancer. 1996;32A Suppl 4:S5-16. Review.PMID: 8976816 [PubMed - indexed for MEDLINE]Related articles

Curative chemotherapy for acute myeloid leukemia: the development of high-dose ara-C from the laboratory to bedside.

Capizzi RL.

Invest New Drugs. 1996;14(3):249-56. Review.PMID: 8958179 [PubMed - indexed for MEDLINE]Related articles

Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purging.

Douay L, Hu C, Giarratana MC, Bouchet S, Conlon J, Capizzi RL, Gorin NC.

Blood. 1995 Oct 1;86(7):2849-55.PMID: 7670119 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B study.

Fleming RA, Capizzi RL, Rosner GL, Oliver LK, Smith SJ, Schiffer CA, Silver RT, Peterson BA, Weiss RB, Omura GA, et al.

Cancer Chemother Pharmacol. 1995;36(5):425-30.PMID: 7634384 [PubMed - indexed for MEDLINE]Related articles

Protection of normal tissue from the cytotoxic effects of chemotherapy and radiation by amifostine: clinical experiences.

Capizzi RL, Oster W.

Eur J Cancer. 1995;31A Suppl 1:S8-13. Review.PMID: 7577096 [PubMed - indexed for MEDLINE]Related articles

Protection of normal tissues from the cytotoxic effects of chemotherapy by amifostine (Ethyol): clinical experiences.

Capizzi RL.

Semin Oncol. 1994 Oct;21(5 Suppl 11):8-15. Review.PMID: 7973776 [PubMed - indexed for MEDLINE]Related articles

Methotrexate content in squamous cell carcinoma of the head and neck after low-dose methotrexate.

Schifeling DJ, George T, McGuirt F, Capizzi RL, Kamen BA.

Med Pediatr Oncol. 1994;22(2):88-90.PMID: 8259106 [PubMed - indexed for MEDLINE]Related articles

Amifostine-mediated protection of normal bone marrow from cytotoxic chemotherapy.

Capizzi RL, Scheffler BJ, Schein PS.

Cancer. 1993 Dec 1;72(11 Suppl):3495-501. Review.PMID: 8242582 [PubMed - indexed for MEDLINE]Related articles

Purification and characterization of deoxycytidine kinase from acute myeloid leukemia cell mitochondria.

Wang LM, Kucera GL, Capizzi RL.

Biochim Biophys Acta. 1993 Oct 6;1202(2):309-16.PMID: 8399394 [PubMed - indexed for MEDLINE]Related articles

Asparaginase revisited.

Capizzi RL.

Leuk Lymphoma. 1993;10 Suppl:147-50. Review. No abstract available. PMID: 8481663 [PubMed - indexed for MEDLINE]Related articles

General aspects of cancer chemotherapy in the aged.

Fleming RA, Capizzi RL.

Adv Exp Med Biol. 1993;330:271-86. Review. No abstract available. PMID: 8368138 [PubMed - indexed for MEDLINE]Related articles

Rapid intravenous infusion of amphotericin B: a pilot study.

Cruz JM, Peacock JE Jr, Loomer L, Holder LW, Evans GW, Powell BL, Lyerly ES, Capizzi RL.

Am J Med. 1992 Aug;93(2):123-30.PMID: 1497007 [PubMed - indexed for MEDLINE]Related articles

1-beta-D-arabinofuranosylcytosine-diphosphate-choline is formed by the reversal of cholinephosphotransferase and not via cytidylyltransferase.

Kucera GL, Capizzi RL.

Cancer Res. 1992 Jul 15;52(14):3886-91.PMID: 1377599 [PubMed - indexed for MEDLINE]Related articlesFree article

Modulation of the cellular pharmacokinetics of ara-CTP in human leukemic blasts by dipyridamole.

Yang JL, White JC, Capizzi RL.

Cancer Chemother Pharmacol. 1992;29(3):236-40.PMID: 1733557 [PubMed - indexed for MEDLINE]Related articles

Deoxypyrimidine-induced inhibition of the cytokinetic effects of 1-beta-D-arabinofuranosyluracil.

Chandrasekaran B, Kute TE, Capizzi RL.

Cancer Chemother Pharmacol. 1992;29(6):455-60.PMID: 1568288 [PubMed - indexed for MEDLINE]Related articles

Leukapheresis induced changes in cell cycle distribution and nucleoside transporters in patients with untreated acute myeloid leukemia.

Powell BL, Gregory BW, Evans JK, White JC, Lyerly ES, Chorley HM, Russell GB, Capizzi RL.

Leukemia. 1991 Dec;5(12):1037-42.PMID: 1774952 [PubMed - indexed for MEDLINE]Related articles

Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association.

Muss HB, Case LD, Richards F 2nd, White DR, Cooper MR, Cruz JM, Powell BL, Spurr CL, Capizzi RL.

N Engl J Med. 1991 Nov 7;325(19):1342-8.PMID: 1922236 [PubMed - indexed for MEDLINE]Related articles

Insurance coverage of screening mammography and Pap smears. The directors of North Carolina's University-based cancer centers speak out.

Bast RC Jr, Capizzi RL, Pagano JS, Wiley AL Jr.

N C Med J. 1991 Oct;52(10):496-8. No abstract available. PMID: 1944619 [PubMed - indexed for MEDLINE]Related articles

S-phase fraction is not correlated with nucleoside transport in acute myeloid leukemia cells.

Powell BL, White JC, Gregory BW, Brockschmidt JK, Rhinehardt-Clark A, Lyerly ES, Chorley HM, Capizzi RL.

Leukemia. 1991 Jul;5(7):598-601.PMID: 2072744 [PubMed - indexed for MEDLINE]Related articles

Effect of dose on the pharmacokinetic and pharmacodynamic effects of cytarabine.

Capizzi RL, White JC, Powell BL, Perrino F.

Semin Hematol. 1991 Jul;28(3 Suppl 4):54-69. Review.PMID: 1780754 [PubMed - indexed for MEDLINE]Related articles

A critical role for uridine nucleotides in the regulation of deoxycytidine kinase and the concentration dependence of 1-beta-D-arabinofuranosylcytosine phosphorylation in human leukemia cells.

White JC, Capizzi RL.

Cancer Res. 1991 May 15;51(10):2559-65.PMID: 2021937 [PubMed - indexed for MEDLINE]Related articlesFree article

The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer.

Marsh JC, Bertino JR, Katz KH, Davis CA, Durivage HJ, Rome LS, Richards F 2nd, Capizzi RL, Farber LR, Pasquale DN, et al.

J Clin Oncol. 1991 Mar;9(3):371-80.PMID: 1999706 [PubMed - indexed for MEDLINE]Related articles

Antimetabolites.

Capizzi RL, White JC, Fernandes DJ.

Baillieres Clin Haematol. 1991 Jan;4(1):15-45. Review. No abstract available. PMID: 2039856 [PubMed - indexed for MEDLINE]Related articles

Ether-linked phosphoglyceride content of human leukemia cells.

Chabot MC, Greene DG, Brockschmidt JK, Capizzi RL, Wykle RL.

Cancer Res. 1990 Nov 15;50(22):7174-8.PMID: 2224852 [PubMed - indexed for MEDLINE]Related articlesFree article

High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association.

Muss HB, Case LD, Capizzi RL, Cooper MR, Cruz J, Jackson D, Richards F 2nd, Powell BL, Spurr CL, White D, et al.

J Clin Oncol. 1990 Nov;8(11):1797-805.PMID: 2230868 [PubMed - indexed for MEDLINE]Related articles

Correlation of the proliferative index of residual leukemia with outcome in patients treated with sequential high dose ara-C and asparaginase.

Powell BL, Kute TE, Craig JB, Lyerly ES, Gregory BW, Do KA, Contento MM, Capizzi RL.

Leukemia. 1990 May;4(5):316-20.PMID: 2388477 [PubMed - indexed for MEDLINE]Related articles

Interaction of granulocytopenia and construction activity as risk factors for nosocomial invasive filamentous fungal disease in patients with hematologic disorders.

Weber SF, Peacock JE Jr, Do KA, Cruz JM, Powell BL, Capizzi RL.

Infect Control Hosp Epidemiol. 1990 May;11(5):235-42.PMID: 2351809 [PubMed - indexed for MEDLINE]Related articles

A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphoma.

Muss HB, Spell N, Scudiery D, Capizzi RL, Cooper MR, Cruz J, Jackson DV, Richards F 2nd, Spurr CL, White DR, et al.

Invest New Drugs. 1990 Feb;8(1):125-30.PMID: 2345067 [PubMed - indexed for MEDLINE]Related articles

Leukemia: experimental and preclinical studies.

Capizzi RL.

Curr Opin Oncol. 1990 Feb;2(1):10-7. Review. No abstract available. PMID: 2095215 [PubMed - indexed for MEDLINE]Related articles

Enhanced retention of cytosine arabinoside and its metabolites and synergistic cytotoxicity by sequential treatment with dipyridamole in L5178Y leukemia.

Yang JL, White JC, Capizzi RL.

Cancer Chemother Pharmacol. 1990;26(2):135-8.PMID: 2347039 [PubMed - indexed for MEDLINE]Related articles

Bromodeoxyuridine incorporation into DNA of human leukemia cells is not concentration dependent.

Powell BL, Gregory BW, Kute TE, Morgan TM, Lyerly ES, Capizzi RL.

Cytometry. 1990;11(3):438-41.PMID: 2340778 [PubMed - indexed for MEDLINE]Related articles

The effect of ara-C-induced inhibition of DNA synthesis on its cellular pharmacology.

Wang LM, White JC, Capizzi RL.

Cancer Chemother Pharmacol. 1990;25(6):418-24.PMID: 2311169 [PubMed - indexed for MEDLINE]Related articles